Hyaluronic Acid for Hypofractionated Prostate Radiotherapy
NCT02165020
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DEVICE:
Hyaluronic acid (Macrolane VRF 30®, Q-MED)
Sponsor
Hospices Civils de Lyon